Furthermore, we identified numerous CTS transcriptional signatures whose expression was significantly associated with prognosis in colon cancer, such as CEBPB, PPARGC1, STAT3, MTOR, BCL2, JAK2, and CDK1. This evidence concerns the gene BCL2 and colonic neoplasm.